<DOC>
	<DOCNO>NCT00814060</DOCNO>
	<brief_summary>This study examine bioavailability ( rate extent active ingredient active moiety absorb drug product become available site action ) two tablet formulation Neratinib ( HKI-272 ) compare capsule formulation .</brief_summary>
	<brief_title>Study Evaluating TwoTablet Formulations Neratinib ( HKI-272 )</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject , age 1850 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>